Drug consumption attitudes in children with suspected drug allergies after de-labelling with drug provocation tests
Thesis Type: Expertise In Medicine
Institution Of The Thesis: Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey
Approval Date: 2024
Thesis Language: Turkish
Student: ŞEYMA KAYA AĞARGÜN
Supervisor: Cevdet Özdemir
Open Archive Collection: AVESIS Open Access Collection
Abstract:Introduction and Objectives: Drug hypersensitivity reactions are assumed to affect approximately 7% of the general population, with a lower incidence in children. Misdiagnosing drug allergies can lead to unnecessary drug restrictions, resulting in the use of more expensive, less effective, and more toxic medications. The aim of this study is to retrospectively evaluate the medical history, clinical, and laboratory findings of pediatric patients who presented with suspected drug allergy. The main focus is to examine their attitudes towards using the medication after excluding the drug allergy with a negative drug provocation test (DPT). Material and Methods: This study, approved by the Ethics Committee of Clinical Research at Istanbul University Istanbul Faculty of Medicine, examined the data of patients who visited the Pediatric Allergy and Immunology Clinic with suspected drug allergies and underwent DPTs between January 2019 and June 2023. Medical history, clinical findings, family history, and laboratory data were collected retrospectively. Questions regarding the use of the drug after DPT were asked during clinic visits. Results: Among the patients included in the study, 55.1% were male and 44.9% were female. A total of 254 DPTs were performed on 198 patients; 180 with suspected drugs and 18 with similar drugs. Drug allergy was confirmed in 27.9% of the patients. Diagnosis was made through skin prick tests in 2 patients (3 tests) and DPT in 48 patients (53 tests). The usage rate of the drug, after the allergy suspicion was removed by DPT, was found to be 57%. Among the patients who used the drug, 92.4% had no issues, while 7.6% reported problems. Of those who did not use the drug (43%), 59% cited ongoing concerns, 37% stated there was no need to use the drug, and 4% did not understand that the allergy suspicion had been ruled out. The rate of using the drug with the allergy label removed was higher in patients with additional allergic diseases compared to those without (65.3% vs. 44.8%; p=0.010), and higher in those who presented with suspicion of drug allergy themselves compared to those referred by another doctor (84.6% vs. 52.5%; p=0.003). Conclusion: The usage rate of 57% for the medication after the allergy label was removed by DPT, with 43% of patients not using the medication due to concerns and similar reasons, underscores the importance of confirming drug allergy diagnoses and the necessity of providing more information to families. To increase the use of medications with the removed allergy label, detailed information should be provided to families and patients should be regularly monitored. Keywords: delabelling, drug allergy, drug hypersensitivity reaction, drug provocation test